Transcriptional silencing of the inhibin-α gene in human gastric carcinoma cells

International Journal of Oncology

Volumn 41, Issue 2, 2012, Pages 690-700

  Kim, Young Il ^a,b   Shim, Jaejun ^c   Kim, Byung Ho ^c   Lee, Sung Jae ^d   Lee, Ha Kyu ^d   Cho, Chunghee ^e   Cho, Byung Nam ^d  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Hypermethylation; Inhibin ; Silencing; Stomach

Indexed keywords

AZACITIDINE; INHIBIN A; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN;

5' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; DNA ISOLATION; DNA METHYLATION; GENE ACTIVATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; AZACITIDINE; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INHIBINS; LOSS OF HETEROZYGOSITY; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 84863594409     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1472     Document Type: Article

References (47)

1. Ying SY: Inhibins and activins: chemical properties and biological activity. Proc Soc Exp Biol Med 186: 253-264, 1987.
2. Ying SY: Inhibins, activins, follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 9: 267-293, 1988.
3. Robertson DM, Giacometti M, Foulds LM, Lahnstein J, Goss NH, Hearn MTW and de Kretser DM: Isolation of inhibin α-subunit precursor proteins from bovine follicular fluid. Endocrinology 125: 2141-2149, 1989. (Pubitemid 19258653)
4. Cchain. Biochem Biophys Res Commun 206: 608-613, 1995.
5. Oda S, Nishimatsu S, Murakami K and Ueno N: Molecular cloning and functional analysis of a new activin β subunit: a dorsal mesoderm-inducing activity in Xenopus. Biochem Biophys Res Commun 210: 581-588, 1995.
6. E subunit gene. Biochem Biophys Res Commun 228: 669-674, 1996.
7. de Kretser DM, Hedger MP, Loveland KL and Phillips DJ: Inhibins, activins and follistatin in reproduction. Hum Reprod Update 8: 529-541, 2002. (Pubitemid 35476797)
8. Findlay JK, Drummond AE, Dyson ML, Baillie AJ, Robertson DM and Ethier JF: Recruitment and development of the follicle; the roles of the transforming growth factor-β superfamily. Mol Cell Endocrinol 191: 35-43, 2002. (Pubitemid 34578577)
9. Juengel JL and McNatty KP: The role of proteins of the transforming growth factor-β superfamily in the intraovarian regulation of follicular development. Hum Reprod Update 11: 144-161, 2005.
10. Knight PG and Glister C: TGF-β superfamily members and ovarian follicle development. Reproduction 132: 191-206, 2006. (Pubitemid 44274724)
11. Chand AL, Ooi GT, Harrison CA, Shelling AN and Robertson DM: Functional analysis of the human inhibin αsubunit variant A257T and its potential role in premature ovarian failure. Hum Reprod 22: 3241-3248, 2007. (Pubitemid 351696784)
12. Welt CK, Taylor AE, Fox J, Messerlian GM, Adams JM and Schneyer AL: Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. J Clin Endocrinol Metab 90: 5582-5587, 2005. (Pubitemid 41415462)
13. Hamar BD, Buhimschi IA, Sfakianaki AK, Pettker CM, Magloire LK, Funai EF, Copel JA and Buhimschi CS: Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia. Am J Obstet Gynecol 195: 1636-1645, 2006. (Pubitemid 44792629)
14. Tsigkou A, Marrelli D, Reis FM, et al: Total inhibin is a potential serum marker for epithelial ovarian cancer. J Clin Endocrinol Metab 92: 2526-2531, 2007. (Pubitemid 47037353)
15. Tsigkou A, Luisi S, Reis FM and Petraglia F: Inhibins as diagnostic markers in human reproduction. Adv Clin Chem 45: 1-29, 2008.
16. Cho BN, McMullen ML, Pei L, Yates CJ and Mayo KE: Reproductive deficiencies in transgenic mice expressing the rat inhibin α-subunit gene. Endocrinology 142: 4994-5004, 2001. (Pubitemid 33022376)
17. Ahn JM, Jung HK, Cho C, Choi D, Mayo KE, and Cho BN: Changes in the reproductive functions of mice due to injection of a plasmid expressing an inhibin α-subunit into muscle: a transient transgenic model. Mol Cell 18: 79-86, 2004. (Pubitemid 39386658)
18. Luisi S, Florio P, Reis FM and Petraglia F: Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy. Hum Reprod Update 11: 123-135, 2005. (Pubitemid 40439506)
19. Risbridger GP, Schmitt JF and Robertson DM: Activins and inhibins in endocrine and other tumors. Endocr Rev 22: 836-858, 2001. (Pubitemid 34214298)
20. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ and Bradley A: α-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360: 313-319, 1992. (Pubitemid 23000668)
21. Matzuk MM and Bradley A: Identification and analysis of tumor suppressor genes using transgenic mouse models. Semin Cancer Biol 5: 37-45, 1994. (Pubitemid 124006634)
22. Matzuk MM, Finegold MJ, Mather JP, Krummen L, Lu H and Bradley A: Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA 91: 8817-8821, 1994.
23. Schmitt JF, Millar DS, Pedersen JS, et al: Hypermethylation of the inhibin α-subunit gene in prostate carcinoma. Mol Endocrinol 16: 213-220, 2002. (Pubitemid 34131220)
24. Balanathan P, Ball EMA, Wang H, Harris SE, Shelling AN and Risbridger GP: Epigenetic regulation of inhibin α-subunit gene in prostate cancer cell lines. J Mol Endocrinol 32: 55-67, 2004. (Pubitemid 38312621)
25. Balanathan P, Williams ED, Wang H, et al: Elevated level of inhibin-α subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer. Br J Cancer 100: 1784-1793, 2009.
26. Imai K, Khandoker MAM, Yonai M, et al: Matrix metalloproteinases-2 and -9 activities in bovine follicular fluid of different-sized follicles: relationship to intra-follicular inhibin and steroid concentrations. Domest Anim Endocrinol 24: 171-183, 2003. (Pubitemid 36238327)
27. Jones RL, Findlay JK, Farnworth PG, Robertson DM, Wallace E, and Salamonsen LA: Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology 147: 724-732, 2006. (Pubitemid 43112988)
28. Hempel N, How T, Dong M, Murphy SK, Fields TA and Blobe GC: Loss of betaglycan expression in ovarian cancer: role in motility and invasion. Cancer Res 67: 5231-5238, 2007. (Pubitemid 46997261)
29. Clark SJ, Harrison J, Paul CL and Frommer M: High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22: 2990-2997, 1994. (Pubitemid 24260626)
30. Sundblad V, Chiauzzi VA, Andreone L, Campo S, Charreau EH and Dain L: Controversial role of inhibin α-subunit gene in the aetiology of premature ovarian failure. Hum Reprod 21: 1154-1160, 2006.
31. Jones PA and Baylin SB: 2002 The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428, 2002. (Pubitemid 34587077)
32. Song SH, Jong HS, Choi HH, Inoue H, Tanabe T, Kim NK, and Bang YJ: Transcriptional silencing of cyclooxygenase-2 by hyper-methylation of the 5′ CpG island in human gastric carcinoma cells. Cancer Res 61: 4628-4635, 2001. (Pubitemid 32685799)
33. Kuchler RJ: Development of animal cell populations in vitro. In: Biochemical Methods in Cell Culture and Virology. Kuchler RJ (ed). Dowden, Hutchinson and Ross Inc. Press, Stroudsburg, PA, pp90-113, 1977.
34. Garinis GA, Patrinos GP, Spanakis NE and Menounos PG: DNA hypermethylation: when tumour suppressor genes go silent. Hum Genet 111: 115-127, 2002. (Pubitemid 36075029)
35. Watson RH, Roy WJ, Davis M, Hitchcock A and Campbell IG: Loss of heterozygosity at the α-inhibin locus on chromosome 2q is not a feature of human granulosa cell tumors. Gynecol Oncol 65: 387-390, 1997. (Pubitemid 27255975)
36. Marozzi A, Porta C, Vegetti W, Crosignani PG, Tibiletti MG, Dalpra L and Ginelli E: Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Hum Reprod 17: 1741-1745, 2002. (Pubitemid 34790294)
37. Stenvers KL and Findlay JK: Inhibins: from reproductive hormones to tumor suppressors. Trends Endocrinol Metab 21: 174-180, 2010.
38. B on human and mouse chromosomes and studies of jsd mice. Genomics 5: 91-99, 1898.
39. Mellor SL, Richards MG, Pedersen JS, Robertson DM and Risbridger GP: Loss of the expression and localization of inhibin α-subunit in high grade prostate cancer. J Clin Endocrinol Metab 83: 969-975, 1998. (Pubitemid 28496478)
40. Vitale AM, Gonzalez OM, Parborell F, Irusta G, Campo S and Tesone M: Inhibin A increases apoptosis in early ovarian antral follicles of diethylstilbestrol-treated rats. Biol Reprod 67: 1989-1995, 2002. (Pubitemid 35388031)
41. Steller MD, Shaw TJ, Vanderhyden BC and Ethier JF: Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells. Mol Cancer Res 3: 50-61, 2005. (Pubitemid 40189596)
42. Geng LY, Fang M, Yi JM, Jiang F, Moeen-ud-Din M and Yang LG: Effect of overexpression of inhibin α (1-32) fragment on bovine granulosa cell proliferation, apoptosis, steroidogenesis, and development of co-cultured oocytes. Theriogenology 70: 35-43, 2008.
43. Myers M, Middlebrook BS, Matzuk MM and Pangas SA: Loss of inhibin alpha uncouples oocyte-granulosa cell dynamics and disrupts postnatal folliculogenesis. Dev Biol 334: 458-467, 2009.
44. Oka M, Meacham AM, Hamazaki T, Rodić N, Chang LJ and Terada N: De novo D NA m ethyltransferases D nmt3a a nd Dnmt3b primarily mediate the cytotoxic effect of 5-aza-2′-deoxycytidine. Oncogene 24: 3091-3099, 2005. (Pubitemid 40695078)
45. Fulda S and Debatin KM: 5-Aza-2′-deoxycytidine and IFN-γcooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8. Oncogene 25: 5125-5133, 2006. (Pubitemid 44285981)
46. Valdez BC, Li Y, Murray D, Corn P, Champlin RE and Andersson BS: 5-Aza-2′-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis. Leuk Res 34: 364-372, 2010.
47. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.